Aegros welcomes the Vietnam Ministry of Health delegation to Macquarie Park – the first overseas government to visit and inspect our Haemafrac® technology, and our newly completed plant.
Aegros was honoured to welcome a high-level delegation from the Ministry of Health of the Socialist Republic of Vietnam to its newly completed Macquarie Park facility on 19 June 2026. This marked a significant moment in Aegros’ international engagement as the first visit by a foreign government to our newly completed plasma fractionation plant. Led […]
Aegros Completes Haemafrac® Plasma Fractionation Facility and Undertakes First Fractionation Runs in Macquarie Park
SYDNEY, AUSTRALIA, 3rd July 2026 – Aegros Therapeutics today announced the completion of its Haemafrac® plasma fractionation facility at Macquarie Park, Sydney. Capable of processing 125,000 litres of human plasma annually, the facility is now undertaking commissioning and engineering fractionation runs ahead of its first TGA GMP regulatory audit this year. A Reimagined Approach to […]
Aegros Secures Final Funding for Completion of its 125,000 Litre Haemafrac® Facility
Aegros Secures Final Funding for Completion of its 125,000 Litre Haemafrac® Facility Yolanda Redrup July 3, 2025 An Australian biotech start-up hoping to emulate the success of blood plasma giant CSL has secured a $37 million lifeline eight months after it was forced to suspend operations unable to repay mounting debts. Staff at Aegros were […]
Aegros Announces Major Changes to its Management Team and Board of Directors
Aegros Announces Major Changes to its Management Team and Board of Directors Aegros – an Australian clinical-stage biopharmaceutical company and global technology leader in the development and manufacture of plasma-derived medical products (PDMPs), today announced significant changes to its Management Team and Board of Directors. Mr. Damian Thornton is appointed Chief Executive Officer of Aegros […]
